Literature DB >> 20399610

Potential stigma associated with inclusion of the psychosis risk syndrome in the DSM-V: an empirical question.

Lawrence H Yang1, Ahtoy J Wonpat-Borja, Mark G Opler, Cheryl M Corcoran.   

Abstract

While the "clinical high-risk state" for psychosis has demonstrated good reliability and fair predictive validity for psychotic disorders, over 50% of identified subjects do not progress to psychosis. Despite the benefits that early detection and treatment might offer, debate concerning the official inclusion of a "psychosis risk syndrome" in the upcoming DSM-V frequently involves concerns about the impact of stigma on patients, families and institutions. We add to this debate by providing an analysis of the theoretical and empirical stigma literature to evaluate the potential effects of stigma associated with the psychosis risk syndrome. Theorists' conceptualizations of how stigma exerts its negative effects emphasize internalization of pejorative societal stereotypes ('self-stigma'), negative emotional reactions, harmful behavioral coping strategies, and structural discrimination as key mechanisms. Studies assessing the comparative effects of symptomatic behavior when compared with a psychiatric diagnosis label in predicting rejecting social attitudes indicate that treating symptomatic behaviors is likely to diminish overall stigma. However, any publically held 'preexisting conceptions' about what a psychosis risk syndrome means are still likely to exert negative effects. Additionally, particular features of this syndrome--that it occurs during adolescence when identity formation may be in flux--may also shape manifestations of stigma. Utilizing other well-established 'at-risk' conditions (e.g., genetic susceptibility) to model potential discrimination for this syndrome, we suggest that future discrimination is likely to occur in insurance and family domains. We conclude by proposing stigma measurement strategies, including recommending that field trials prior to DSM-V adopt systematic measures to assess any stigma that this psychosis risk syndrome might confer via future community use. (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20399610      PMCID: PMC2921374          DOI: 10.1016/j.schres.2010.03.012

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  41 in total

1.  Culture and stigma: adding moral experience to stigma theory.

Authors:  Lawrence Hsin Yang; Arthur Kleinman; Bruce G Link; Jo C Phelan; Sing Lee; Byron Good
Journal:  Soc Sci Med       Date:  2006-12-22       Impact factor: 4.634

2.  The passage to adulthood: challenges of late adolescence.

Authors:  Nicole Zarrett; Jacquelynne Eccles
Journal:  New Dir Youth Dev       Date:  2006

3.  Stigma starts early: gender differences in teen willingness to use mental health services.

Authors:  Anita Chandra; Cynthia S Minkovitz
Journal:  J Adolesc Health       Date:  2006-06       Impact factor: 5.012

4.  Psychotic-like experiences in nonpsychotic help-seekers: associations with distress, depression, and disability.

Authors:  Alison R Yung; Joe A Buckby; Sue M Cotton; Elizabeth M Cosgrave; Eoin J Killackey; Carrie Stanford; Katherine Godfrey; Patrick D McGorry
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

5.  Prodromal interventions for schizophrenia vulnerability: the risks of being "at risk".

Authors:  Cheryl Corcoran; Dolores Malaspina; Laura Hercher
Journal:  Schizophr Res       Date:  2005-03-01       Impact factor: 4.939

6.  Stigma as a barrier to recovery: The consequences of stigma for the self-esteem of people with mental illnesses.

Authors:  B G Link; E L Struening; S Neese-Todd; S Asmussen; J C Phelan
Journal:  Psychiatr Serv       Date:  2001-12       Impact factor: 3.084

7.  Stigmatisation of people with mental illnesses.

Authors:  A H Crisp; M G Gelder; S Rix; H I Meltzer; O J Rowlands
Journal:  Br J Psychiatry       Date:  2000-07       Impact factor: 9.319

8.  Women with BRCA1 or BRCA2 mutations renegotiating a post-prophylactic mastectomy identity: self-image and self-disclosure.

Authors:  Regina H Kenen; Pamela J Shapiro; Liisa Hantsoo; Susan Friedman; James C Coyne
Journal:  J Genet Couns       Date:  2007-10-05       Impact factor: 2.537

9.  Stigmatizing attitudes and beliefs about treatment and psychiatric medications for children with mental illness.

Authors:  Bernice A Pescosolido; Brea L Perry; Jack K Martin; Jane D McLeod; Peter S Jensen
Journal:  Psychiatr Serv       Date:  2007-05       Impact factor: 3.084

10.  Perceived dangerousness of children with mental health problems and support for coerced treatment.

Authors:  Bernice A Pescosolido; Danielle L Fettes; Jack K Martin; John Monahan; Jane D McLeod
Journal:  Psychiatr Serv       Date:  2007-05       Impact factor: 3.084

View more
  40 in total

1.  Causal Beliefs and Effects upon Mental Illness Identification Among Chinese Immigrant Relatives of Individuals with Psychosis.

Authors:  Lawrence H Yang; Ahtoy J Wonpat-Borja
Journal:  Community Ment Health J       Date:  2011-11-11

2.  Psychosis risk screening with the Prodromal Questionnaire--brief version (PQ-B).

Authors:  Rachel L Loewy; Rahel Pearson; Sophia Vinogradov; Carrie E Bearden; Tyrone D Cannon
Journal:  Schizophr Res       Date:  2011-04-20       Impact factor: 4.939

3.  Effects of labeling and interpersonal contact upon attitudes towards schizophrenia: implications for reducing mental illness stigma in urban China.

Authors:  Lawrence H Yang; Graciete Lo; Ahtoy J WonPat-Borja; Daisy R Singla; Bruce G Link; Michael R Phillips
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-11-11       Impact factor: 4.328

4.  Eugenics, genetics, and mental illness stigma in Chinese Americans.

Authors:  Ahtoy J WonPat-Borja; Lawrence H Yang; Bruce G Link; Jo C Phelan
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-11-16       Impact factor: 4.328

5.  Stigma related to labels and symptoms in individuals at clinical high-risk for psychosis.

Authors:  Lawrence H Yang; Bruce G Link; Shelly Ben-David; Kelly E Gill; Ragy R Girgis; Gary Brucato; Ahtoy J Wonpat-Borja; Cheryl M Corcoran
Journal:  Schizophr Res       Date:  2015-08-25       Impact factor: 4.939

Review 6.  Antipsychotic interventions in prodromal psychosis: safety issues.

Authors:  Chen-Chung Liu; Arsime Demjaha
Journal:  CNS Drugs       Date:  2013-03       Impact factor: 5.749

7.  Using biomarkers to inform diagnosis, guide treatments and track response to interventions in psychotic illnesses.

Authors:  Veronica B Perez; Neal R Swerdlow; David L Braff; Risto Näätänen; Gregory A Light
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

8.  The 'at-risk mental state' for psychosis in adolescents: clinical presentation, transition and remission.

Authors:  Patrick Welsh; Paul A Tiffin
Journal:  Child Psychiatry Hum Dev       Date:  2014-02

9.  Public stigma associated with psychosis risk syndrome in a college population: implications for peer intervention.

Authors:  Lawrence H Yang; Deidre M Anglin; Ahtoy J Wonpat-Borja; Mark G Opler; Michelle Greenspoon; Cheryl M Corcoran
Journal:  Psychiatr Serv       Date:  2013-03-01       Impact factor: 3.084

Review 10.  Progress and Future Directions in Research on the Psychosis Prodrome: A Review for Clinicians.

Authors:  Kristen A Woodberry; Daniel I Shapiro; Caitlin Bryant; Larry J Seidman
Journal:  Harv Rev Psychiatry       Date:  2016 Mar-Apr       Impact factor: 3.732

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.